List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. Industry Value Chain Analysis 18
Figure 5. Asia Pacific Hemodynamic Monitoring Systems Market, 2021-2031, $ mn 19
Figure 6. Impact of COVID-19 on Business 22
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Hemodynamic Monitoring Systems Market 24
Figure 8. Worldwide Prevalence of Cardiovascular Disorders, 1990-2019, million 27
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 30
Figure 11. Primary Restraints and Impact Factors of Asia Pacific Hemodynamic Monitoring Systems Market 32
Figure 12. Investment Opportunity Analysis 36
Figure 13. Porter’s Fiver Forces Analysis of Asia Pacific Hemodynamic Monitoring Systems Market 39
Figure 14. Breakdown of Asia Pacific Hemodynamic Monitoring Systems Market by Component, 2021-2031, % of Revenue 44
Figure 15. Asia Pacific Addressable Market Cap in 2022-2031 by Component, Value ($ mn) and Share (%) 44
Figure 16. Asia Pacific Hemodynamic Monitoring Systems Market by Component: Catheters, 2021-2031, $ mn 45
Figure 17. Asia Pacific Hemodynamic Monitoring Systems Market by Component: Sensors, 2021-2031, $ mn 46
Figure 18. Asia Pacific Hemodynamic Monitoring Systems Market by Component: Monitoring Devices, 2021-2031, $ mn 47
Figure 19. Asia Pacific Hemodynamic Monitoring Systems Market by Component: Probes, 2021-2031, $ mn 48
Figure 20. Asia Pacific Hemodynamic Monitoring Systems Market by Component: Other Components, 2021-2031, $ mn 49
Figure 21. Breakdown of Asia Pacific Hemodynamic Monitoring Systems Market by Modality, 2021-2031, % of Sales Revenue 51
Figure 22. Asia Pacific Addressable Market Cap in 2022-2031 by Modality, Value ($ mn) and Share (%) 51
Figure 23. Asia Pacific Hemodynamic Monitoring Systems Market by Modality: Invasive Monitoring, 2021-2031, $ mn 52
Figure 24. Asia Pacific Hemodynamic Monitoring Systems Market by Modality: Minimally Invasive Monitoring, 2021-2031, $ mn 53
Figure 25. Asia Pacific Hemodynamic Monitoring Systems Market by Modality: Non-Invasive Monitoring, 2021-2031, $ mn 54
Figure 26. Breakdown of Asia Pacific Hemodynamic Monitoring Systems Market by Setting, 2021-2031, % of Sales Revenue 56
Figure 27. Asia Pacific Addressable Market Cap in 2022-2031 by Setting, Value ($ mn) and Share (%) 56
Figure 28. Asia Pacific Hemodynamic Monitoring Systems Market by Setting: Hospitals, 2021-2031, $ mn 57
Figure 29. Asia Pacific Hemodynamic Monitoring Systems Market by Setting: Clinics, 2021-2031, $ mn 58
Figure 30. Asia Pacific Hemodynamic Monitoring Systems Market by Setting: Ambulatory Care Units, 2021-2031, $ mn 59
Figure 31. Asia Pacific Hemodynamic Monitoring Systems Market by Setting: Homecare, 2021-2031, $ mn 60
Figure 32. Asia Pacific Hemodynamic Monitoring Systems Market by Setting: Other Settings, 2021-2031, $ mn 61
Figure 33. Breakdown of APAC Hemodynamic Monitoring Systems Market by Country, 2021 and 2031, % of Revenue 63
Figure 34. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 64
Figure 35. Hemodynamic Monitoring Systems Market in Japan, 2021-2031, $ mn 66
Figure 36. Hemodynamic Monitoring Systems Market in China, 2021-2031, $ mn 69
Figure 37. Hemodynamic Monitoring Systems Market in Australia, 2021-2031, $ mn 71
Figure 38. Hemodynamic Monitoring Systems Market in India, 2021-2031, $ mn 73
Figure 39. Hemodynamic Monitoring Systems Market in South Korea, 2021-2031, $ mn 75
Figure 40. Hemodynamic Monitoring Systems Market in Rest of APAC, 2021-2031, $ mn 77
Figure 41. Growth Stage of Asia Pacific Hemodynamic Monitoring Systems Industry over the Forecast Period 79
Asia Pacific hemodynamic monitoring systems market will grow by 8.0% annually with a total addressable market cap of $4,242.7 million over 2022-2031, driven by the rising prevalence of cardiovascular diseases & diabetes, increasing geriatric population, the introduction of more innovative and non-invasive devices, extensive research and development (R&D) activities, and the increasing healthcare concerns and expenditure amid COVID-19 pandemic. Highlighted with 28 tables and 41 figures, this 105-page report “Asia Pacific Hemodynamic Monitoring Systems Market 2021-2031 by Component (Catheters, Sensors, Monitoring Devices, Probes, Others), Modality (Invasive, Minimally Invasive, Non-Invasive), Setting (Hospitals, Clinics, Ambulatory Care Units, Homecare, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific hemodynamic monitoring systems market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific hemodynamic monitoring systems market in every aspect of the classification from perspectives of Component, Modality, Setting, and Country. Based on Component, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Catheters • Sensors • Monitoring Devices • Probes • Other Components Based on Modality, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Invasive Monitoring • Minimally Invasive Monitoring • Non-Invasive Monitoring By Setting, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Clinics • Ambulatory Care Units • Homecare • Other Settings Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Modality, and Setting over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Baxter International Inc. Caretaker, LLC Cheetah Medical Inc. CN Systems Medizintechnik GmbH Deltex Medical Group PLC Dragerwerk AG & Co. KGaA Edwards Lifesciences Corporation Flosonics Medical GE Healthcare Getinge Group Heart Kinetics ICU Medical Inc. Koninklijke Philips N.V. Lidco Group PLC Masimo Corporation NI Medical Ltd. Osypka Medical GmbH Retia Medical Schwarzer Cardiotek Sramek BioDynamics Inc. Uscom Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More